Influence of Granulocyte-Macrophage Colony-Stimulating Factor or Influenza Vaccination on HLA-DR, Infection and Delirium Days in Immunosuppressed Surgical Patients: Double Blind, Randomised Controlled Trial.
Surgical patients are at high risk for developing infectious complications and postoperative delirium. Prolonged infections and delirium result in worse outcome. Granulocyte-macrophage colony-stimulating factor (GM-CSF) and influenza vaccination are known to increase HLA-DR on monocytes and improve...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4671639?pdf=render |
_version_ | 1811286640086220800 |
---|---|
author | Claudia Spies Alawi Luetz Gunnar Lachmann Markus Renius Clarissa von Haefen Klaus-Dieter Wernecke Marcus Bahra Alexander Schiemann Marco Paupers Christian Meisel |
author_facet | Claudia Spies Alawi Luetz Gunnar Lachmann Markus Renius Clarissa von Haefen Klaus-Dieter Wernecke Marcus Bahra Alexander Schiemann Marco Paupers Christian Meisel |
author_sort | Claudia Spies |
collection | DOAJ |
description | Surgical patients are at high risk for developing infectious complications and postoperative delirium. Prolonged infections and delirium result in worse outcome. Granulocyte-macrophage colony-stimulating factor (GM-CSF) and influenza vaccination are known to increase HLA-DR on monocytes and improve immune reactivity. This study aimed to investigate whether GM-CSF or vaccination reverses monocyte deactivation. Secondary aims were whether it decreases infection and delirium days after esophageal or pancreatic resection over time.In this prospective, randomized, placebo-controlled, double-blind, double dummy trial setting on an interdisciplinary ICU of a university hospital 61 patients with immunosuppression (monocytic HLA-DR [mHLA-DR] <10,000 monoclonal antibodies [mAb] per cell) on the first day after esophageal or pancreatic resection were treated with either GM-CSF (250 μg/m2/d), influenza vaccination (Mutagrip 0.5 ml/d) or placebo for a maximum of 3 consecutive days if mHLA-DR remained below 10,000 mAb per cell. HLA-DR on monocytes was measured daily until day 5 after surgery. Infections and delirium were followed up for 9 days after surgery. Primary outcome was HLA-DR on monocytes, and secondary outcomes were duration of infection and delirium.mHLA-DR was significantly increased compared to placebo (p < 0.001) and influenza vaccination (p < 0.001) on the second postoperative day. Compared with placebo, GM-CSF-treated patients revealed shorter duration of infection (p < 0.001); the duration of delirium was increased after vaccination (p = 0.003).Treatment with GM-CSF in patients with postoperative immune suppression was safe and effective in restoring monocytic immune competence. Furthermore, therapy with GM-CSF reduced duration of infection in immune compromised patients. However, influenza vaccination increased duration of delirium after major surgery.www.controlled-trials.com ISRCTN27114642. |
first_indexed | 2024-04-13T03:03:36Z |
format | Article |
id | doaj.art-d3e6ac27ce0743ed906224d934b9a532 |
institution | Directory Open Access Journal |
issn | 1932-6203 |
language | English |
last_indexed | 2024-04-13T03:03:36Z |
publishDate | 2015-01-01 |
publisher | Public Library of Science (PLoS) |
record_format | Article |
series | PLoS ONE |
spelling | doaj.art-d3e6ac27ce0743ed906224d934b9a5322022-12-22T03:05:21ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-011012e014400310.1371/journal.pone.0144003Influence of Granulocyte-Macrophage Colony-Stimulating Factor or Influenza Vaccination on HLA-DR, Infection and Delirium Days in Immunosuppressed Surgical Patients: Double Blind, Randomised Controlled Trial.Claudia SpiesAlawi LuetzGunnar LachmannMarkus ReniusClarissa von HaefenKlaus-Dieter WerneckeMarcus BahraAlexander SchiemannMarco PaupersChristian MeiselSurgical patients are at high risk for developing infectious complications and postoperative delirium. Prolonged infections and delirium result in worse outcome. Granulocyte-macrophage colony-stimulating factor (GM-CSF) and influenza vaccination are known to increase HLA-DR on monocytes and improve immune reactivity. This study aimed to investigate whether GM-CSF or vaccination reverses monocyte deactivation. Secondary aims were whether it decreases infection and delirium days after esophageal or pancreatic resection over time.In this prospective, randomized, placebo-controlled, double-blind, double dummy trial setting on an interdisciplinary ICU of a university hospital 61 patients with immunosuppression (monocytic HLA-DR [mHLA-DR] <10,000 monoclonal antibodies [mAb] per cell) on the first day after esophageal or pancreatic resection were treated with either GM-CSF (250 μg/m2/d), influenza vaccination (Mutagrip 0.5 ml/d) or placebo for a maximum of 3 consecutive days if mHLA-DR remained below 10,000 mAb per cell. HLA-DR on monocytes was measured daily until day 5 after surgery. Infections and delirium were followed up for 9 days after surgery. Primary outcome was HLA-DR on monocytes, and secondary outcomes were duration of infection and delirium.mHLA-DR was significantly increased compared to placebo (p < 0.001) and influenza vaccination (p < 0.001) on the second postoperative day. Compared with placebo, GM-CSF-treated patients revealed shorter duration of infection (p < 0.001); the duration of delirium was increased after vaccination (p = 0.003).Treatment with GM-CSF in patients with postoperative immune suppression was safe and effective in restoring monocytic immune competence. Furthermore, therapy with GM-CSF reduced duration of infection in immune compromised patients. However, influenza vaccination increased duration of delirium after major surgery.www.controlled-trials.com ISRCTN27114642.http://europepmc.org/articles/PMC4671639?pdf=render |
spellingShingle | Claudia Spies Alawi Luetz Gunnar Lachmann Markus Renius Clarissa von Haefen Klaus-Dieter Wernecke Marcus Bahra Alexander Schiemann Marco Paupers Christian Meisel Influence of Granulocyte-Macrophage Colony-Stimulating Factor or Influenza Vaccination on HLA-DR, Infection and Delirium Days in Immunosuppressed Surgical Patients: Double Blind, Randomised Controlled Trial. PLoS ONE |
title | Influence of Granulocyte-Macrophage Colony-Stimulating Factor or Influenza Vaccination on HLA-DR, Infection and Delirium Days in Immunosuppressed Surgical Patients: Double Blind, Randomised Controlled Trial. |
title_full | Influence of Granulocyte-Macrophage Colony-Stimulating Factor or Influenza Vaccination on HLA-DR, Infection and Delirium Days in Immunosuppressed Surgical Patients: Double Blind, Randomised Controlled Trial. |
title_fullStr | Influence of Granulocyte-Macrophage Colony-Stimulating Factor or Influenza Vaccination on HLA-DR, Infection and Delirium Days in Immunosuppressed Surgical Patients: Double Blind, Randomised Controlled Trial. |
title_full_unstemmed | Influence of Granulocyte-Macrophage Colony-Stimulating Factor or Influenza Vaccination on HLA-DR, Infection and Delirium Days in Immunosuppressed Surgical Patients: Double Blind, Randomised Controlled Trial. |
title_short | Influence of Granulocyte-Macrophage Colony-Stimulating Factor or Influenza Vaccination on HLA-DR, Infection and Delirium Days in Immunosuppressed Surgical Patients: Double Blind, Randomised Controlled Trial. |
title_sort | influence of granulocyte macrophage colony stimulating factor or influenza vaccination on hla dr infection and delirium days in immunosuppressed surgical patients double blind randomised controlled trial |
url | http://europepmc.org/articles/PMC4671639?pdf=render |
work_keys_str_mv | AT claudiaspies influenceofgranulocytemacrophagecolonystimulatingfactororinfluenzavaccinationonhladrinfectionanddeliriumdaysinimmunosuppressedsurgicalpatientsdoubleblindrandomisedcontrolledtrial AT alawiluetz influenceofgranulocytemacrophagecolonystimulatingfactororinfluenzavaccinationonhladrinfectionanddeliriumdaysinimmunosuppressedsurgicalpatientsdoubleblindrandomisedcontrolledtrial AT gunnarlachmann influenceofgranulocytemacrophagecolonystimulatingfactororinfluenzavaccinationonhladrinfectionanddeliriumdaysinimmunosuppressedsurgicalpatientsdoubleblindrandomisedcontrolledtrial AT markusrenius influenceofgranulocytemacrophagecolonystimulatingfactororinfluenzavaccinationonhladrinfectionanddeliriumdaysinimmunosuppressedsurgicalpatientsdoubleblindrandomisedcontrolledtrial AT clarissavonhaefen influenceofgranulocytemacrophagecolonystimulatingfactororinfluenzavaccinationonhladrinfectionanddeliriumdaysinimmunosuppressedsurgicalpatientsdoubleblindrandomisedcontrolledtrial AT klausdieterwernecke influenceofgranulocytemacrophagecolonystimulatingfactororinfluenzavaccinationonhladrinfectionanddeliriumdaysinimmunosuppressedsurgicalpatientsdoubleblindrandomisedcontrolledtrial AT marcusbahra influenceofgranulocytemacrophagecolonystimulatingfactororinfluenzavaccinationonhladrinfectionanddeliriumdaysinimmunosuppressedsurgicalpatientsdoubleblindrandomisedcontrolledtrial AT alexanderschiemann influenceofgranulocytemacrophagecolonystimulatingfactororinfluenzavaccinationonhladrinfectionanddeliriumdaysinimmunosuppressedsurgicalpatientsdoubleblindrandomisedcontrolledtrial AT marcopaupers influenceofgranulocytemacrophagecolonystimulatingfactororinfluenzavaccinationonhladrinfectionanddeliriumdaysinimmunosuppressedsurgicalpatientsdoubleblindrandomisedcontrolledtrial AT christianmeisel influenceofgranulocytemacrophagecolonystimulatingfactororinfluenzavaccinationonhladrinfectionanddeliriumdaysinimmunosuppressedsurgicalpatientsdoubleblindrandomisedcontrolledtrial |